FN2 Earnings Intelligence
Pfizer Inc. income statement (quarterly)
Pfizer Inc. (PFE) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/29/2024 | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/29/2026 est. | 9/29/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,092 | $1,430 | $1,638 | $1,343 | $1,703 | - | - |
| + Debt | $67,701 | $62,109 | $61,797 | $61,712 | $64,455 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $17,702 | $13,715 | $14,653 | $16,654 | $14,451 | $14,416.7 | $16,153.4 |
| % Growth | - | - | - | - | - | -1.6% | -3.0% |
| Gross Profit | $2,157 | $10,870 | $10,875 | $12,482 | $10,903 | - | - |
| % Margin | 12.2% | 79.3% | 74.2% | 74.9% | 75.4% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $4,465 | $2,967 | $2,910 | $3,541 | $2,687 | - | - |
| % Margin | 25.2% | 21.6% | 19.9% | 21.3% | 18.6% | - | - |
| Diluted EPS | $0.78 | $0.52 | $0.51 | $0.62 | $0.47 | $0.68 | $0.82 |
| % Growth | - | - | - | - | - | 33.4% | 32.4% |
| Operating Cash Flow | - | $2,335 | - | - | $2,615 | - | - |
| CapEx | - | $564 | - | - | $436 | - | - |
| Free Cash Flow | - | $1,771 | - | - | $2,179 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/29/2024 | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 | 6/29/2026 est. | 9/29/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $17,702 | $13,715 | $14,653 | $16,654 | $14,451 | $14,416.7 | $16,153.4 |
| Gross Profit | $2,157 | $10,870 | $10,875 | $12,482 | $10,903 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $4,465 | $2,967 | $2,910 | $3,541 | $2,687 | - | - |
| Diluted EPS | $0.78 | $0.52 | $0.51 | $0.62 | $0.47 | $0.68 | $0.82 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/29/2024 | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,092 | $1,430 | $1,638 | $1,343 | $1,703 |
| Short-term Debt | $9,699 | $4,470 | $4,295 | $4,303 | $3,890 |
| Long-term Debt | $58,002 | $57,639 | $57,502 | $57,409 | $60,565 |
| Total Debt | $67,701 | $62,109 | $61,797 | $61,712 | $64,455 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/29/2024 | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $2,335 | - | - | $2,615 |
| Capital Expenditure | - | $564 | - | - | $436 |
| Free Cash Flow | - | $1,771 | - | - | $2,179 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/29/2024 | 3/30/2025 | 6/29/2025 | 9/28/2025 | 3/29/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 12.2% | 79.3% | 74.2% | 74.9% | 75.4% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 25.2% | 21.6% | 19.9% | 21.3% | 18.6% |
| FCF Margin | - | 12.9% | - | - | 15.1% |
| Diluted EPS Growth | - | - | - | - | - |